H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 151,950. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Pasadena clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Pasadena storefront.
Non-Opioid Pain Management Solutions in Pasadena, TX for clinics & physicians. Non-opioid pain management… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. 32.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick non opioid pain management against that mix.
National Non-Opioid Pain Management Solutions notes (how the product actually works)CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Adult obesity in Pasadena is 39.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 20.1% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 32.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 39.1%; arthritis is 20.1%. That is place-level BRFSS modeling, not a clinic census and not a Pasadena trial.
It is the Census city-proper count — useful as scale for a city under 250k. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
No. areaServed names the city we will ship to. It is not a claim that Hawk Medical is a Pasadena medical practice or that we hold a local facility license.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers non-opioid pain management solutions and which products they use.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Pasadena fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Pasadena, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Pasadena is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Pasadena — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Pasadena. Useful for joint-program math; still needs a diagnosis and privileging.
No Pasadena storefront. Joe Bradley is an active practice owner. non opioid pain management stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.